Palliative treatment of benign prostatic hypertrophy; value of glycine-alanine-glutamic acid combination.
D000409:Alanine / Q000627:therapeutic use*; D004151:Dipeptides; D007887:Fabaceae; D005971:Glutamates / Q000627:therapeutic use*; D018698:Glutamic Acid; D005998:Glycine / Q000627:therapeutic use*; D006801:Humans; D006984:Hypertrophy; D008297:Male; D010166:Palliative Care; D011470:Prostatic Hyperplasia / Q000628:therapy*
D004151:Dipeptides; D005971:Glutamates; D018698:Glutamic Acid; C028872:alanylglycine; D000409:Alanine; D005998:Glycine
ALANINE/therapeutic use; GLUTAMATES/therapeutic use; GLYCINE/therapeutic use; PROSTATE HYPERTROPHY/therapy